This article has been updated with comments from the FDA.

The FDA has asked the Environmental Protection Agency to leave the FDA out of its proposal for stricter regulation of ethylene oxide (EtO) emissions, and the EPA complied.
In an interagency comment on the EPA’s proposed rule governing commercial EtO users — which includes medical device sterilization plants — the FDA suggested omitting a section in which the EPA discusses medtech sterilization.
Get the full story on our sister site, Medical Design & Outsourcing.